| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Thomas Kidrin last filed a Form 4 in May 2019, as Director at MRMD. Thomas Kidrin's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 6,073,673 shares of MRMD. The MRMD filings lean toward selling, a net 432,994 shares.
Thomas Kidrin has 3 Form 4 filings on record from January 2018 to May 2019, all as Director at Marimed (MRMD), 2018–2019.
The 7 reported transactions were 7 open-market sales.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $790K.
The largest open-market sale was 300,000 shares of MRMD at an average $1.22 on February 1, 2018, about $365K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.